comparemela.com
Latest Breaking News On - Global surgical segment - Page 1 : comparemela.com
Ecolab Gains After Beating Q1 Sales Expectations And Raising FY24 Outlook; Divests Surgical Segment For $950M - Ecolab (NYSE:ECL)
Ecolab surges post-Q1 with sales beat, raised FY24 outlook, and plans to sell surgical segment for $950M cash.
Christophe-beck
Ecolab-inc
Pest-elimination
Global-surgical-segment
vimarsana © 2020. All Rights Reserved.